These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 27687621

  • 21. Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome.
    Basu B, Preussler S, Sander A, Mahapatra TKS, Schaefer F.
    BMC Nephrol; 2020 Nov 30; 21(1):520. PubMed ID: 33256621
    [Abstract] [Full Text] [Related]

  • 22. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y.
    Pediatr Nephrol; 2015 Jul 30; 30(7):1121-9. PubMed ID: 25773534
    [Abstract] [Full Text] [Related]

  • 23. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J, Ehrich JH, Querfeld U.
    Nephrol Dial Transplant; 2012 May 30; 27(5):1970-8. PubMed ID: 21976740
    [Abstract] [Full Text] [Related]

  • 24. Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
    Ravani P, Ponticelli A, Siciliano C, Fornoni A, Magnasco A, Sica F, Bodria M, Caridi G, Wei C, Belingheri M, Ghio L, Merscher-Gomez S, Edefonti A, Pasini A, Montini G, Murtas C, Wang X, Muruve D, Vaglio A, Martorana D, Pani A, Scolari F, Reiser J, Ghiggeri GM.
    Kidney Int; 2013 Nov 30; 84(5):1025-33. PubMed ID: 23739238
    [Abstract] [Full Text] [Related]

  • 25. Ofatumumab for the treatment of childhood nephrotic syndrome.
    Wang CS, Liverman RS, Garro R, George RP, Glumova A, Karp A, Jernigan S, Warshaw B.
    Pediatr Nephrol; 2017 May 30; 32(5):835-841. PubMed ID: 28213687
    [Abstract] [Full Text] [Related]

  • 26. Fifteen-year remission of a steroid-resistant nephrotic syndrome sustained by cyclosporine A.
    Drube J, Geerlings C, Taylor R, Mengel M, Ehrich JH.
    Pediatr Nephrol; 2007 Apr 30; 22(4):600-2. PubMed ID: 17235550
    [Abstract] [Full Text] [Related]

  • 27. Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
    Fujinaga S, Hirano D, Mizutani A, Sakuraya K, Yamada A, Sakurai S, Shimizu T.
    Clin Exp Nephrol; 2017 Aug 30; 21(4):671-676. PubMed ID: 27558467
    [Abstract] [Full Text] [Related]

  • 28. Efficacy and Safety of Rituximab in Children With Steroid- and Cyclosporine-resistant and Steroid- and Cyclosporine-dependent Nephrotic Syndrome.
    Hoseini R, Sabzian K, Otukesh H, Zafaranloo N, Panahi P, Rahimzadeh N, Nakhaie S, Akhavan Sepehi M.
    Iran J Kidney Dis; 2018 Jan 30; 12(1):27-32. PubMed ID: 29421774
    [Abstract] [Full Text] [Related]

  • 29. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.
    Fujinaga S, Ohtomo Y, Hirano D, Nishizaki N, Someya T, Ohtsuka Y, Kaneko K, Shimizu T.
    Clin Nephrol; 2009 Oct 30; 72(4):268-73. PubMed ID: 19825332
    [Abstract] [Full Text] [Related]

  • 30. Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine.
    Fujinaga S, Hirano D, Nishizaki N, Kamei K, Ito S, Ohtomo Y, Shimizu T, Kaneko K.
    Pediatr Nephrol; 2010 Mar 30; 25(3):539-44. PubMed ID: 20049616
    [Abstract] [Full Text] [Related]

  • 31. New treatment strategies in idiopathic nephrotic syndrome.
    Ulinski T, Aoun B.
    Minerva Pediatr; 2012 Apr 30; 64(2):135-43. PubMed ID: 22495188
    [Abstract] [Full Text] [Related]

  • 32. [Treatment of children with steroid-dependent nephrotic syndrome with rituximab].
    Huang J, Du J, Wang S, Xiao L, Zhao X.
    Zhonghua Er Ke Za Zhi; 2014 Jul 30; 52(7):521-4. PubMed ID: 25224058
    [Abstract] [Full Text] [Related]

  • 33. Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery.
    Sellier-Leclerc AL, Baudouin V, Kwon T, Macher MA, Guérin V, Lapillonne H, Deschênes G, Ulinski T.
    Nephrol Dial Transplant; 2012 Mar 30; 27(3):1083-9. PubMed ID: 21810762
    [Abstract] [Full Text] [Related]

  • 34. Age and memory B cells at baseline are associated with risk of relapse and memory B-cell reappearance following anti-CD20 treatment in pediatric frequently-relapsing/steroid-dependent nephrotic syndrome.
    Colucci M, Angeletti A, Zotta F, Carsetti R, Lugani F, Ravà L, Ravani P, Emma F, Ghiggeri GM, Vivarelli M.
    Kidney Int; 2023 Sep 30; 104(3):577-586. PubMed ID: 37385541
    [Abstract] [Full Text] [Related]

  • 35. Mycophenolate Mofetil Following Rituximab in Children With Steroid-Resistant Nephrotic Syndrome.
    Basu B, Mahapatra TK, Mondal N.
    Pediatrics; 2015 Jul 30; 136(1):e132-9. PubMed ID: 26101364
    [Abstract] [Full Text] [Related]

  • 36. Ofatumumab in post-transplantation recurrence of a pediatric steroid-resistant idiopathic nephrotic syndrome.
    Bernard J, Bruel A, Allain-Launay E, Dantal J, Roussey G.
    Pediatr Transplant; 2018 Jun 30; 22(4):e13175. PubMed ID: 29569812
    [Abstract] [Full Text] [Related]

  • 37. Switch from cyclosporine A to mycophenolate mofetil in nephrotic children.
    Ulinski T, Dubourg L, Saïd MH, Parchoux B, Ranchin B, Cochat P.
    Pediatr Nephrol; 2005 Apr 30; 20(4):482-5. PubMed ID: 15719253
    [Abstract] [Full Text] [Related]

  • 38. Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome.
    Iijima K, Sako M, Oba M, Tanaka S, Hamada R, Sakai T, Ohwada Y, Ninchoji T, Yamamura T, Machida H, Shima Y, Tanaka R, Kaito H, Araki Y, Morohashi T, Kumagai N, Gotoh Y, Ikezumi Y, Kubota T, Kamei K, Fujita N, Ohtsuka Y, Okamoto T, Yamada T, Tanaka E, Shimizu M, Horinochi T, Konishi A, Omori T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Nozu K, Japanese Study Group of Kidney Disease in Children.
    J Am Soc Nephrol; 2022 Feb 30; 33(2):401-419. PubMed ID: 34880074
    [Abstract] [Full Text] [Related]

  • 39. Late-onset adverse events after a single dose of rituximab in children with complicated steroid-dependent nephrotic syndrome.
    Fujinaga S, Ozawa K, Sakuraya K, Yamada A, Shimizu T.
    Clin Nephrol; 2016 Jun 30; 85(6):340-5. PubMed ID: 27125626
    [Abstract] [Full Text] [Related]

  • 40. Rituximab for very low dose steroid-dependent nephrotic syndrome in children: a randomized controlled study.
    Ravani P, Lugani F, Pisani I, Bodria M, Piaggio G, Bartolomeo D, Prunotto M, Ghiggeri GM.
    Pediatr Nephrol; 2020 Aug 30; 35(8):1437-1444. PubMed ID: 32232637
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.